Supernus Pharmaceuticals
SUPN
$46.24
Share price
-2.18%
Change (1 day)
4.83%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : C$0.47 Billion
According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.47 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$0.47 B | 0.96% |
| 2023-12-31 | C$0.47 B | -57.35% |
| 2022-12-31 | C$1.10 B | -0.47% |
| 2021-12-31 | C$1.11 B | 14.97% |
| 2020-12-31 | C$0.96 B | 31.22% |
| 2019-12-31 | C$0.73 B | 3.2% |
| 2018-12-31 | C$0.71 B | 262.2% |
| 2017-12-31 | C$0.19 B | 24.66% |
| 2016-12-31 | C$0.15 B | 13.43% |
| 2015-12-31 | C$0.13 B | 25.18% |
| 2014-12-31 | C$0.11 B | 35.11% |
| 2013-12-31 | C$82.53 M | 127.89% |
| 2012-12-31 | C$36.21 M | -19.61% |
| 2011-12-31 | C$45.04 M | -50.65% |
| 2010-12-31 | C$91.29 M | 0.82% |
| 2009-12-31 | C$90.54 M | -11.22% |
| 2008-12-31 | C$0.10 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | C$1.31 B | 176.82% | 🇺🇸 USA |
 | C$92.17 B | 19,290.77% | 🇺🇸 USA |
 | C$109.01 B | 22,832.84% | 🇺🇸 USA |
 | C$47.93 B | 9,983.95% | 🇺🇸 USA |
 | C$155.35 B | 32,581.59% | 🇺🇸 USA |